Genetics of coronary artery disease in the 21st century

Clinical Cardiology

Volumn 35, Issue 9, 2012, Pages 536-540

  Roberts, Robert ^a   Stewart, Alexandre F R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; MORBIDITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RISK FACTORS;

EID: 84866236604     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22002     Document Type: Review

References (38)

1. Kannel WB, Dawber TR, Kagan A, et al. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med. 1961; 55: 33-50.
2. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Rockville, MD: National Center for Chronic Disease Prevention and Health Promotion; 2004.
3. Shepherd J, Cobbe SM, Ford I, et al. West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333: 1301-1308.
4. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA. 1998; 279: 1615-1622.
5. Wald NJ, Law MR., A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003; 326: 1419-1423.
6. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-952.
7. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007; 316: 1488-1491.
8. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007; 316: 1491-1493.
9. Chan L, Boerwinkle E., Gene-environment interactions and gene therapy in atherosclerosis. Cardiol Rev. 1994; 2: 130-137.
10. Schildkraut JM, Myers RM, Cupples LA, et al. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol. 1989; 64: 555-559.
11. Colditz GA, Rimm EB, Giovannucci E, et al. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol. 1991; 67: 933-938.
12. Hopkins PN, Williams RR, Kuida H, et al. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol. 1988; 62 (10 part 1): 703-707.
13. Rissanen A., Familial occurrence of coronary heart disease: effect of age at diagnosis. Am J Cardiol. 1979; 44: 60-66.
14. Allen G, Harvald B, Shields JP., Measures of twin concordance. Acta Genet Stat Med. 1967; 17: 475-481.
15. Cooper JA, Miller GJ, Humphries SE., A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis. 2005; 181: 93-100.
16. Hamosh A, Scott AF, Amberger J, et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2002; 30: 52-55.
17. Hirshhorn JN, Daly MJ., Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005; 6: 95-108.
18. Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007; 315: 848-853.
19. Roberts R, Stewart AF, Wells GA, et al. Identifying genes for coronary artery disease: an idea whose time has come. Can J Cardiol. 2007; 23 (suppl A): 7A-15A.
20. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009; 106: 9362-9367.
21. National Institutes of Health, National Human Genome Research Institute; Hindorff LA, MacArthur J, Wise A, et al. A catalog of published genome-wide association studies. http://www.genome.gov/gwastudies. Updated April 2012. Accessed January 15, 2012.
22. Dandona S, Stewart AF, Roberts R., Genomics in coronary artery disease: past, present and future. Can J Cardiol. 2010; 26 (suppl A): 56A-59A.
23. CARDIoGRAM Consortium. Design of the Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) Study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovas Genet. 2010; 3: 475-483.
24. Schunkert H, König IR, Kathiresan S, et al. CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011; 43: 333-338.
25. Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011; 377: 383-392.
26. Peden JF, Hopewell JC, Saleheen D, et al. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011; 43: 339-344.
27. Wang F, Xu CQ, He Q, et al. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet. 2011; 43: 345-349.
28. The IBC, 50K CAD Consortium. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 2011; 7: e1002260.
29. Dandona S, Stewart AF, Chen L, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol. 2009; 56: 479-486.
30. Chen Z, Qian Q, Wang J, et al. A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease. Mol Biol Rep. 2009; 36: 889-893.
31. Patel RS, Su S, Neeland IJ, et al. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. Eur Heart J. 2010; 31: 3017-3023.
32. Ardissino D, Berzuini C, Merlini PA, et al. Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. J Am Coll Cardiol. 2011; 58: 426-434.
33. Medalie JH, Levene C, Papier C, et al. Blood groups, myocardial infarction and angina pectoris among 10 000 adult males. N Engl J Med. 1971; 285: 1348-1353.
34. Reid ME, Mohandas N., Red blood cell blood group antigens: structure and function. Semin Hematol. 2004; 41: 93-117.
35. Gill JC, Endres-Brooks J, Bauer PJ, et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987; 69: 1691-1695.
36. Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA. 1994; 271: 999-1003.
37. Di Angelantonio E, Sarwar N, Perry P, et al. the Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009; 302: 1993-2000.
38. Sesso HD, Stampfer MJ, Rosner B, et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension. 2000; 36: 801-807.